Haemonetics Slumps as CSL Plasma Declines to Renew a Supply Pact
About 12% of Haemonetics 2020 revenue came from a contract with CSL Plasma. CSL declined to renew the accord.
Author:
Shares of Haemonetics Corp. (
HAE) - Get Report dropped Monday after the medical device maker said CSL Plasma declined to renew an agreement to use one of its products in the U.S.
CSL Plasma is the Boca Raton, Fla., network of centers that pay donors for plasma donations. It's a unit of CSL Ltd., CMXHF the Melbourne, Australia, biotech company.
Once the current agreement expires in June 2022, CSL will no longer use the Haeomonetics PCS2 Plasma Collection System devices and will no longer purchase disposable plasmapheresis kits in the U.S.